Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 17Multiple Myeloma 12Ovarian Neoplasms 9Recurrence 8Lymphoma, B-Cell 8Pancreatic Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma 7Hodgkin Disease 7Burkitt Lymphoma 7Colorectal Neoplasms 6Myeloproliferative Disorders 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Biphenotypic, Acute 5Stomach Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia 4Hematologic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Urogenital Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Osteosarcoma 3Melanoma 3Lymphoma, Follicular 3Leukemia, B-Cell 3

Interventions

fludarabine 1dehydroftorafur 1binimetinib 1Specimen Handling 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Fluorouracil 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Klatskin Tumor × fludarabine × 30 days × Clear all
NCT07614061 2026-05-29

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Shanghai Zhongshan Hospital

Phase 1 Recruiting
18 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡